Pharmacological Treatment of Presbyopia Using Pilocarpine 1.25% Eye Drops

Purpose: To assess the efficiency and safety of pilocarpine eye drop 1.25% analogue (IRPilo) in comparison with its original brand-name drug (Vuity). Methods: In this non-randomized comparative study, 75 patients with presbyopia aged 40 to 60 years were enrolled. The right eyes of these patients r...

Full description

Saved in:
Bibliographic Details
Main Authors: Seyed Abolghasem Mousavi, Zhale Rajavi, Hamideh Sabbaghi, Saeid Abdi, Nafeeseh Montazerin, Bahareh Kheiri, Azadeh Haseli- Monfared, Kourosh Sheibani, Hemn Baghban Jaldian
Format: Article
Language:English
Published: Knowledge E 2024-12-01
Series:Journal of Ophthalmic & Vision Research
Subjects:
Online Access:https://knepublishing.com/index.php/JOVR/article/view/14578
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832592697132580864
author Seyed Abolghasem Mousavi
Zhale Rajavi
Hamideh Sabbaghi
Saeid Abdi
Nafeeseh Montazerin
Bahareh Kheiri
Azadeh Haseli- Monfared
Kourosh Sheibani
Hemn Baghban Jaldian
author_facet Seyed Abolghasem Mousavi
Zhale Rajavi
Hamideh Sabbaghi
Saeid Abdi
Nafeeseh Montazerin
Bahareh Kheiri
Azadeh Haseli- Monfared
Kourosh Sheibani
Hemn Baghban Jaldian
author_sort Seyed Abolghasem Mousavi
collection DOAJ
description Purpose: To assess the efficiency and safety of pilocarpine eye drop 1.25% analogue (IRPilo) in comparison with its original brand-name drug (Vuity). Methods: In this non-randomized comparative study, 75 patients with presbyopia aged 40 to 60 years were enrolled. The right eyes of these patients received either IR-Pilo (n = 45) or Vuity (n = 30) and their contralateral eyes served as controls. Refractive errors, distance best-corrected visual acuity (BCVA), near vision, amplitude of accommodation, pupil size, and intraocular pressure (IOP) were measured before and 1 to 2 hours after instillation of the eye drop. Results: The mean refractive error was stable, except for a small myopic shift in the Vuity group. There was no significant change in distance BCVA. Near vision improved significantly in both intervention groups (P < 0.001) with preference for IR-Pilo (4 vs 2.3). Furthermore, a higher amplitude of accommodation and pupil constriction occurred after instillation of both drops, with a higher effect associated with IR-Pilo. However, IOP did not change significantly post intervention. Conclusion: IR-Pilo and Vuity eye drops had comparable results; both were effective and led to stable distance vision and improved near vision. Both ophthalmic drugs were safe and none of them were associated with significant adverse effects.
format Article
id doaj-art-2a63867d3ab84638b7da7b29e817528d
institution Kabale University
issn 2008-2010
2008-322X
language English
publishDate 2024-12-01
publisher Knowledge E
record_format Article
series Journal of Ophthalmic & Vision Research
spelling doaj-art-2a63867d3ab84638b7da7b29e817528d2025-01-21T05:15:07ZengKnowledge EJournal of Ophthalmic & Vision Research2008-20102008-322X2024-12-0119410.18502/jovr.v19i4.14578Pharmacological Treatment of Presbyopia Using Pilocarpine 1.25% Eye DropsSeyed Abolghasem Mousavi 0Zhale Rajavi1Hamideh Sabbaghi2Saeid Abdi3Nafeeseh Montazerin4Bahareh Kheiri5Azadeh Haseli- Monfared6Kourosh Sheibani7Hemn Baghban Jaldian8Negah Aref Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IranNegah Aref Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IranOphthalmic Epidemiology Research Center, Research Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, Tehran, IranDepartment of Optometry, School of Rehabilitation, Shahid Beheshti University of Medical Sciences, Tehran, IranNegah Aref Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IranOphthalmic Research Center, Research Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, Tehran, IranNegah Aref Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IranBasir Eye Health Research Center, Tehran, IranDepartment of Optometry, School of Rehabilitation, Shahid Beheshti University of Medical Sciences, Tehran, Iran Purpose: To assess the efficiency and safety of pilocarpine eye drop 1.25% analogue (IRPilo) in comparison with its original brand-name drug (Vuity). Methods: In this non-randomized comparative study, 75 patients with presbyopia aged 40 to 60 years were enrolled. The right eyes of these patients received either IR-Pilo (n = 45) or Vuity (n = 30) and their contralateral eyes served as controls. Refractive errors, distance best-corrected visual acuity (BCVA), near vision, amplitude of accommodation, pupil size, and intraocular pressure (IOP) were measured before and 1 to 2 hours after instillation of the eye drop. Results: The mean refractive error was stable, except for a small myopic shift in the Vuity group. There was no significant change in distance BCVA. Near vision improved significantly in both intervention groups (P < 0.001) with preference for IR-Pilo (4 vs 2.3). Furthermore, a higher amplitude of accommodation and pupil constriction occurred after instillation of both drops, with a higher effect associated with IR-Pilo. However, IOP did not change significantly post intervention. Conclusion: IR-Pilo and Vuity eye drops had comparable results; both were effective and led to stable distance vision and improved near vision. Both ophthalmic drugs were safe and none of them were associated with significant adverse effects. https://knepublishing.com/index.php/JOVR/article/view/14578AccommodationDistance VisionEye DropsNear VisionPresbyopia
spellingShingle Seyed Abolghasem Mousavi
Zhale Rajavi
Hamideh Sabbaghi
Saeid Abdi
Nafeeseh Montazerin
Bahareh Kheiri
Azadeh Haseli- Monfared
Kourosh Sheibani
Hemn Baghban Jaldian
Pharmacological Treatment of Presbyopia Using Pilocarpine 1.25% Eye Drops
Journal of Ophthalmic & Vision Research
Accommodation
Distance Vision
Eye Drops
Near Vision
Presbyopia
title Pharmacological Treatment of Presbyopia Using Pilocarpine 1.25% Eye Drops
title_full Pharmacological Treatment of Presbyopia Using Pilocarpine 1.25% Eye Drops
title_fullStr Pharmacological Treatment of Presbyopia Using Pilocarpine 1.25% Eye Drops
title_full_unstemmed Pharmacological Treatment of Presbyopia Using Pilocarpine 1.25% Eye Drops
title_short Pharmacological Treatment of Presbyopia Using Pilocarpine 1.25% Eye Drops
title_sort pharmacological treatment of presbyopia using pilocarpine 1 25 eye drops
topic Accommodation
Distance Vision
Eye Drops
Near Vision
Presbyopia
url https://knepublishing.com/index.php/JOVR/article/view/14578
work_keys_str_mv AT seyedabolghasemmousavi pharmacologicaltreatmentofpresbyopiausingpilocarpine125eyedrops
AT zhalerajavi pharmacologicaltreatmentofpresbyopiausingpilocarpine125eyedrops
AT hamidehsabbaghi pharmacologicaltreatmentofpresbyopiausingpilocarpine125eyedrops
AT saeidabdi pharmacologicaltreatmentofpresbyopiausingpilocarpine125eyedrops
AT nafeesehmontazerin pharmacologicaltreatmentofpresbyopiausingpilocarpine125eyedrops
AT baharehkheiri pharmacologicaltreatmentofpresbyopiausingpilocarpine125eyedrops
AT azadehhaselimonfared pharmacologicaltreatmentofpresbyopiausingpilocarpine125eyedrops
AT kouroshsheibani pharmacologicaltreatmentofpresbyopiausingpilocarpine125eyedrops
AT hemnbaghbanjaldian pharmacologicaltreatmentofpresbyopiausingpilocarpine125eyedrops